Pfizer and Allergan to Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Pfizer (PFE) And Allergan (AGN) Could Trade 'Range-Bound', Says Deutsche Bank
November 23, 2015 1:57 PM ESTShares of Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) could be 'range-bound' for some time, according to Deutsche Bank analyst Gregg Gilbert. Comments follow news the two companies reached a $160 billion merger agreement.
"Conceptually, we could see both stocks remaining range-bound for some time (close expected in 2H16) as investors of various types consider the merits of the transaction," said Gilbert."This deal, if closed, will make PFE an... More
